Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Cited by (637)

Items 601–637 of 637

1. A cost–utility analysis of thrombopoietin receptor agonists for treating pediatric immune thrombocytopenia purpura after failure of first‐line therapies
   Huimin Du, Jiamin Wang, Joel Livingston, Ziyad Alrajhi, Melanie Ann Kirby-Allen, Brian Chan, Rebecca Hancock, Peter C. Coyte · 2023 · Pediatric Blood & Cancer
2. Extra imaging beyond NCCN surveillance guidelines is cost effective for HPV− but not HPV+ oropharyngeal cancer
   Rema Shah, Sidharth Tyagi, Christina Liu, Benjamin L. Judson · 2023 · Oral Oncology
3. Estimating value of food allergy treatments
   Marcus S Shaker, Elissa Michele Abrams, Sarah Hughes, Matthew Greenhawt · 2023 · Elsevier eBooks
4. UEG Journal's impact and vision for the future
   Omar Elshaarawy, Alberto Balduzzi, Anna Burelli, Zsa Zsa R. M. Weerts · 2024 · United European Gastroenterology Journal
5. Cost-effectiveness evaluations should be based on trials, not models
   Robert M. Kaplan · 2024 · International Journal for Quality in Health Care
6. The anterior-based muscle-sparing approach is cost-effective when compared with posterolateral and direct anterior approaches for total hip arthroplasty
   Adam J. Rana, Neil Askew, Marion B. Noyes, Leo M. Nherera, Johanna A. Mackenzie, Catherine M Call, Brian J. McGrory, George M. Babikian · 2024 · Journal of Medical Economics
7. Cost-utility analysis of a tiered diagnostic approach combining a screening model and polysomnography in pediatric obstructive sleep apnea
   Shenglong Xu, Yanru Li, De-min Han · 2024 · Journal of Clinical Sleep Medicine
8. Bridging the Gap between Longevity and Vitality: The Value of Extending Healthy Life Expectancy
   Yusuke Tanizawa, Kazuya Ito, Ryuta Takashima · 2025 · SSRN Electronic Journal
9. Costs, Value, and Variation
   Matthew A. Pappas, Hannah K. Bassett, Amit K. Pahwa, Michael B. Rothberg · 2025 · Medical Clinics of North America
10. Cost-Utility Analysis of Acupuncture for the Prevention of Episodic Migraine from a Lifetime Canadian Health System and Societal Perspective
    Elizabeth C. Wu, Rebecca Hancock, Brian Chan, Peter C. Coyte · 2025 · Medical Acupuncture
11. Cost-effectiveness of culturally-adapted counselling mental distress in low-income ethnic minorities in Hong Kong: results based on a randomized clinical trial
    Yi Nam Suen, Yik Chun Wong, Ng Winnie, Shilpa Patwardhan, Charlton Cheung, Stephanie Ming Yin Wong, Christy Lai Ming Hui, Michael Tak Hing Wong, Shalini Mahtani, Eric Yu Hai Chen · 2025 · SSM - Mental Health
12. Cost‐Effectiveness of Family Conferences to Reduce Polypharmacy in Frail Older Adults
    Joseph Montalbo, Charalabos‐Markos Dintsios, Jens Abraham, Eva Drewelow, Manuela Ritzke, Achim Mortsiefer, Birgitt Wiese, Petra Thürmann, Stefan Wilm, Andrea Icks et al. · 2025 · Journal of the American Geriatrics Society
13. Value of Early Diagnosis and Treatment of Amyloidosis: A Pilot Study of Synovial Biopsy During Carpal Tunnel Release
    Trevor Ruesch, Nevil Khurana, Logan M. Hansen, Katiya Barkho, Julia I. Malewicz, Benjamin Brennan, Charles S. Day · 2025 · Journal of Hand Surgery Global Online
14. Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective
    Hamza A. Alshannaq, Jéssica Yumi Matuoka, Richard Fulton Pollock, Waqas Ahmed, Peter Matthew Lynch, Gregory J. Norman · 2025 · Journal of Managed Care & Specialty Pharmacy
15. Cost analysis of treatment for periodontitis stages I–IV based on periodontal status and number of visits: a retrospective study at the Dental Teaching Hospital
    A. B., Benso Sulijaya, Yuniarti Soeroso, Natalina Haerani, Fatimah Maria Tadjoedin, Anton Rahardjo · 2025 · Frontiers in Dental Medicine
16. Deriving monetary value of quality-adjusted life years through life extension from the value of a statistical life
    Yusuke Tanizawa, Kazuya Ito, Ryuta Takashima · 2025 · Scientific Reports
17. Current use and potential value of cost-effectiveness analysis in U.S. health care: The case of medicare national coverage determinations
    James D. Chambers · 2012 · Brunel University Research Archive (BURA) (Brunel University London)
18. Internet-based treatment of stress urinary incontinence : treatment outcome, patient satisfaction, and cost-effectiveness
    Malin Sjöström · 2014 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
19. Cost-effectiveness analysis of stereotactic body radiotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: An economic evaluation from a payer's perspective
    Alexander David Steiner · 2014 · eScholarship (California Digital Library)
20. Additional file 1 of Effectiveness of a digitally supported care management programme to reduce unmet needs of family caregivers of people with dementia: study protocol for a cluster randomised controlled trial (GAIN)
    Olga A. Klein, Melanie Boekholt, Dilshad Afrin, Christina Dornquast, Adina Dreier, Armin Keller, Michalowsky, Bernhard, Ina Zwingmann, Teipel, Stefan, Jochen René Thyrian et al. · 2021 · Figshare
21. Additional file 1 of Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method
    Peng, Qian, Yin, Yue, Liang, Min, Zhao, Mingye, Shao, Taihang, Yaqian Tang, Zhiqing Mei, Li, Hao, Tang, Wenxi · 2024 · Figshare
22. Additional file 1 of A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Alyson W. Wong, John Koo, Ryerson, Christopher J., Sadatsafavi, Mohsen, Chen, Wenjia · 2022 · Figshare
23. Preventing invasive aspergillosis in lung transplant recipients: A cost-utility analysis
    Roni Bitterman, Aida I. Glembocki, Laura Naëmi Walti, Shahid Husain, Petros Pechlivanoglou · 2026 · The Journal of Heart and Lung Transplantation
24. Health economic simulation modeling of an AI-enabled clinical decision support system for coronary revascularization
    Tom Mullie, Arjun Puri, Emma Bogner, Bryan Har, Colm J. Murphy, Robert C. Welsh, Benjamin D. Tyrrell, Christopher L. F. Sun, Joon Lee · 2026 · npj Digital Medicine
25. Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials
    Alex A. Francoeur, Su-Ying Liang, B. File, Eunjin Choi, Max Brameld, Michael T. Richardson, Caitlin R. Johnson, D. Kapp, K. Tewari, J. Chan · 2026 · Gynecologic Oncology Reports
26. Maximizing public health benefits: Policy perspectives on coverage and cell-based influenza vaccines in the US
    Văn Hùng Nguyễn, Joaquín Federico Mould-Quevedo · 2026 · Human Vaccines & Immunotherapeutics
27. Coût-efficacité des stratégies vaccinales en France, exemple de trois pathologies infectieuses : le tétanos, la rage et les infections materno-fœtales à cytomégalovirus
    Dieynaba S. N’Diaye · 2014
28. Estimated Glomerular Filtration Rate Slope, Chronic Kidney Disease Progression, and Pillars of Care in Patients With Diabetic Kidney Disease
    Pamela R. Kushner, Christian W. Mende · 2026 · Diabetes Obesity and Cardiometabolic CARE
29. Cost‐Utility Analysis of Indocyanine Green Versus Methylene Blue for Sentinel Lymph Node Biopsy in Breast Cancer
    S L Lee, Ainsley Kohler, Joseph N. Tingen, Caroline A. King, Sarah M. Persing, Christopher Homsy, Salvatore M. Nardello, Abhishek Chatterjee · 2026 · Journal of Surgical Oncology
30. How Much Do We Know About the Mental Health Economic Costs of Disasters?
    Ilan Noy, Tomáš Uher · 2026 · Economics of Disasters and Climate Change
31. Evaluating the potential health and economic impacts of chlamydia vaccination strategies in the United States: a mathematical modeling and cost-effectiveness simulation study
    Gregory Zane, Dobromir Dimitrov, Carol Levin, Christine M. Khosropour, Ann C. Duerr · 2026 · The Lancet Regional Health - Americas
32. Author Reply
    Mina Alizadehsadrdaneshpour, Jacob Smith, Mike Paulden, Eric Nauenberg · 2026 · Value in Health
33. Cost-Effectiveness of Remote Cognitive-Behavioral-Based Therapy for Chronic Pain Among People With High-Impact Chronic Pain
    John F. Dickerson, Maureen O’Keefe-Rosetti, Meghan Mayhew, Andrea J. Cook, Robert Wellman, Francis J. Keefe, Christine Killingsworth Rini, Ashli A. Owen‐Smith, Michael Von Korff, Lynn DeBar · 2026 · Value in Health
34. Long-term study to assess quality of life and cost outcomes of different delayed breast reconstruction techniques: A randomized controlled trial (GoBreast)
    Fredrik Brorson, Emma Hansson, Anna Paganini, Anna Elander, Mikael Svensson · 2026 · Scandinavian Journal of Surgery
35. Economic Evaluation of Mindfulness-Oriented Recovery Enhancement for the Treatment of Opioid Misuse
    Fernando A. Wilson, Eric L. Garland · 2026 · Value in Health
36. Cost-effectiveness of a web-based peer-delivered physical activity program for breast cancer survivors
    Brian K Chen, Madison M. Kindred, Danielle M. Ostendorf, Amy Huebshmann, Ashwin Patel, SHIRA I. DUNSIGER, Bernardine M. Pinto · 2026 · Translational Behavioral Medicine
37. No Significant Difference in Cost or Outcomes at 1‐Year Minimum Follow‐Up After Arthroscopic Partial Meniscectomy Comparing 1.9 mm Distal Chip‐on‐Tip Needlescope Versus 4 mm Glass Rod Lens Arthroscope: Both Treatments Are Highly Cost‐Effective
    James H. Lubowitz, Chad D. Lavender · 2026 · Arthroscopy Sports Medicine and Rehabilitation